Itochu Partners With Device Maker Goodman to Expand Healthcare Business
This article was originally published in PharmAsia News
General trading company Itochu announced a partnership deal with medical device maker and JASDAQ stock exchange listed Goodman Co. Itochu plans to acquire 36.29 percent of Goodman shares to become the largest share holder. The company will pay an average of ¥998 per share, or a total investment of ¥4 billion. Itochu will also appoint one executive director and one non-executive director to Goodman's board. (Click here for more - Japanese language
You may also be interested in...
Gilead says remdesivir improved mortality and clinical recovery in COVID-19 patients, but the findings come from a retrospective analysis, not a traditional clinical trial.
Agency resuming domestic inspections with the help of a pandemic rating system to identify localities where inspections will be safest for investigators and plant workers. Another safety factor: all inspections will be pre-announced.
Poseida, Nkarta and Inventiva raised $224m, $252m and $107.7m, respectively. Also, Forbion raised €185m ($208m) of a new €250m fund and Blackstone closed the last $1.2bn of its $4.6bn fund for public and private company deals, and Ascendis led recent follow-ons with a $569.2m offering.